Compile Data Set for Download or QSAR
maximum 50k data
Found 19 Enz. Inhib. hit(s) with all data for entry = 7014
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)
Affinity DataIC50:  38nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166608(3-(5-Bromo-1-methyl-1H-indol-3-yl)-4-(furo[2,3-b]p...)
Affinity DataIC50:  70nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166606(3-(5-Chloro-1-methyl-1H-indol-3-yl)-4-(furo[2,3-b]...)
Affinity DataIC50:  170nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166613(3-(Furo[2,3-b]pyridin-3-yl)-4-(1-isopropyl-1H-indo...)
Affinity DataIC50:  190nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166615(3-(1-(3-(1H-Imidazol-1-yl)propyl)-5-bromo-1H-indol...)
Affinity DataIC50:  190nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166614(3-(1-(3-(1H-Imidazol-1-yl)propyl)-1H-indol-3-yl)-4...)
Affinity DataIC50:  210nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166616(3-(1-(3-(1H-Imidazol-1-yl)propyl)-5-chloro-1H-indo...)
Affinity DataIC50:  240nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166602(3-(Furo[2,3-b]pyridin-3-yl)-4-(1-methyl-1H-indol-3...)
Affinity DataIC50:  280nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166603(3-(1,7-dimethyl-1H-indol-3-yl)-4-(furo[2,3-b]pyrid...)
Affinity DataIC50:  290nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166617(3-(Furo[2,3-b]pyridin-3-yl)-4-(1-(3-hydroxypropyl)...)
Affinity DataIC50:  310nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166604(3-(5-Fluoro-1-methyl-1H-indol-3-yl)-4-(furo[2,3-b]...)
Affinity DataIC50:  390nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166611(3-(1-Allyl-1H-indol-3-yl)-4-(furo[2,3-b]pyridin-3-...)
Affinity DataIC50:  530nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166605(3-(6-Fluoro-1-methyl-1H-indol-3-yl)-4-(furo[2,3-b]...)
Affinity DataIC50:  560nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166612(3-(1-Butyl-1H-indol-3-yl)-4-(furo[2,3-b]pyridin-3-...)
Affinity DataIC50:  570nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166618(3-(Furo[2,3-b]pyridin-3-yl)-4-(1-(3-morpholinoprop...)
Affinity DataIC50:  690nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166610(3-(Furo[2,3-b]pyridin-3-yl)-4-(5-methoxy-1-methyl-...)
Affinity DataIC50:  1.31E+3nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166601(3-(Furo[2,3-b]pyridin-3-yl)-4-(1H-indol-3-yl)-1H-p...)
Affinity DataIC50:  1.78E+3nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166607(3-(6-Chloro-1-methyl-1H-indol-3-yl)-4-(furo[2,3-b]...)
Affinity DataIC50:  1.84E+3nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Zhejiang University Of Technology

LigandPNGBDBM166609(3-(6-Bromo-1-methyl-1H-indol-3-yl)-4-(furo[2,3-b]p...)
Affinity DataIC50:  1.94E+3nMAssay Description:The test methods for GSK-3β, PKCE, JAK2, BRAF, IKK2 and Drak2 inhibitory activities were reported in Molecules; 18:5498-5516. The PKA kinase ass...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed